Pédiatrie Hématologie EURONET-PHL-C2 European Network-Paediatric Hodgkin Lymphoma Study Group (EuroNet-PHL) Second International Inter-Group Study for Classical Hodgkin Lymphoma in Children and Adolescents Paris
Pédiatrie Neuroblastomes J1O-MC-JZHD A Phase 1 Study of;Aurora Kinase A Inhibitor LY3295668 erbumine as a Single;Agent and in Combination in Patients with;Relapsed/Refractory Neuroblastoma Paris ISABELLE AERTS
Pédiatrie Neuroblastomes HR-NBL2 High-Risk Neuroblastoma Study 2 of SIOP-Europa-Neuroblastoma (SIOPEN) Paris GUDRUN SCHLEIERMACHER
Pédiatrie Neuroblastomes EUSA-PASS (EUSA-DB-0001) A Post-Authorisation Safety Study Patient Registry of Patients With High-risk Neuroblastoma Being Treated With the Monoclonal Antibody Dinutuximab Beta Paris GUDRUN SCHLEIERMACHER
Pédiatrie Neuroblastomes NANT 2015-02 (IC 2018-05) Phase 1 Study of Lorlatinib (PF-06463922), an Oral Small Molecule Inhibitor of ALK/ROS1, for Patients With ALK-Driven Relapsed or Refractory Neuroblastoma Paris GUDRUN SCHLEIERMACHER